Identification of FtfL as a novel target of berberine in intestinal bacteria

BACKGROUND: Berberine (BBR) is a commonly used anti-intestinal inflammation drug, and its anti-cancer activity has been found recently. BBR can intervene and control malignant colorectal cancer (CRC) through intestinal microbes, but the direct molecular target and related mechanism are unclear. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jinci, Fang, Chengli, Yang, Gaohua, Li, Jianxu, Liu, Yanqiang, Zhang, Lu, Yang, Pengjie, Fang, Jingyuan, Gu, Yang, Zhang, Yu, Jiang, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696740/
https://www.ncbi.nlm.nih.gov/pubmed/38049785
http://dx.doi.org/10.1186/s12915-023-01778-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696740/
https://www.ncbi.nlm.nih.gov/pubmed/38049785
http://dx.doi.org/10.1186/s12915-023-01778-w

Ejemplares similares